Filtros de búsqueda

Lista de obras de

"Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II)," by Simon T.

artículo científico publicado en 2004

3',4'-Bis-difluoromethoxycinnamoylanthranilate (FT061): an orally-active antifibrotic agent that reduces albuminuria in a rat model of progressive diabetic nephropathy.

artículo científico publicado en 2013

3′,4′-Dihydroxyflavonol Antioxidant Attenuates Diastolic Dysfunction and Cardiac Remodeling in Streptozotocin-Induced Diabetic m(Ren2)27 Rats ⬇️

artículo científico publicado el 28 de julio de 2011

A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure

artículo científico publicado en 2015

A bioavailability study of cyclosporine: comparison of Neoral versus Cysporin in stable heart transplant recipients

artículo científico publicado en 2009

A feeling in the waters: diagnosis of heart failure using urinary natriuretic peptides

artículo científico publicado en 2004

A novel algorithm for individualized cardiac resynchronization therapy: Rationale and design of the adaptive cardiac resynchronization therapy trial ⬇️

artículo científico publicado el 1 de mayo de 2012

A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients

artículo científico publicado en 2015

A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat

artículo científico publicado en 2012

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

artículo científico publicado en 2016

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2009

A statement on ethics from the HEART Group

artículo científico publicado en 2008

Acute effects of caffeine on heart rate variability

artículo científico publicado en 2002

Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study

artículo científico publicado en 2015

Adherence, adaptation and acceptance of elderly chronic heart failure patients to receiving healthcare via telephone-monitoring

article

Aldosterone blockade in post-acute myocardial infarction heart failure.

artículo científico publicado en 2006

Aldosterone receptor antagonists for hypertension: what do they offer?

artículo científico publicado en 2003

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

artículo científico

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

artículo científico publicado en 2016

Altered sympathetic and parasympathetic activity in lung transplantation patients at rest and following autonomic perturbation

artículo científico publicado en 2002

Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve

artículo científico publicado en 2014

Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers

artículo científico publicado en 2008

Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy

artículo científico publicado en 2014

Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome

artículo científico publicado en 2017

Are all outcomes in chronic heart failure rated equally? An argument for a patient-centred approach to outcome assessment

artículo científico publicado en 2014

Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study

artículo científico publicado en 2006

Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials ⬇️

artículo científico publicado el 1 de noviembre de 2003

Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design

artículo científico publicado en 2007

Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study

artículo científico publicado en 2016

Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial

artículo científico publicado en 2015

Attitudes of Patients and Prescribing Clinicians to Polypharmacy and Medication Withdrawal in Heart Failure.

artículo científico publicado en 2016

B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial

artículo científico publicado en 2009

B-type natriuretic peptide-guided heart failure therapy: A meta-analysis

artículo científico publicado en 2010

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials

artículo científico publicado en 2010

Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program

artículo científico publicado en 2009

Beta-blockers in chronic heart failure: what have we learned? What do we still need to know?

artículo científico publicado en 2003

Blood Pressure and Cardiovascular Outcomes in Patients Taking Nonsteroidal Antiinflammatory Drugs ⬇️

artículo científico publicado el 25 de mayo de 2011

Blood pressure effects of COX-2 inhibitors.

artículo científico publicado en 2006

Bush telegraph. Improving outcomes for rural and remote patients with chronic heart failure

artículo científico publicado en 2004

CHAT--a study of a nurse-led system of care

artículo científico publicado en 2006

CONFIRMATION OF KEY TREAT FINDINGS IN RED-HF, A PLACEBO CONTROLLED HEART FAILURE TRIAL

artículo científico publicado en 2014

Can Renin Status Predict the Antihypertensive Efficacy of Eplerenone Add‐On Therapy? ⬇️

artículo científico publicado el 1 de noviembre de 2003

Can medications be safely withdrawn in patients with stable chronic heart failure? systematic review and meta-analysis

artículo científico

Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?

artículo científico publicado en 2006

Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes

artículo científico publicado en 2018

Cardiac-resynchronization therapy in heart failure with a narrow QRS complex

artículo científico publicado en 2013

Cardiorenal fibrosis and dysfunction in aging: Imbalance in mediators and regulators of collagen

artículo científico publicado en 2016

Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins

artículo científico publicado en 2014

Cardiorenal syndrome: pathophysiology, preclinical models, management and potential role of uraemic toxins.

artículo científico publicado en 2012

Cardiorenal syndrome: role of protein-bound uremic toxins

artículo científico

Cardiovascular Magnetic Resonance GUIDEd management of mild-moderate left ventricular systolic Heart Failure (CMR GUIDE HF): study protocol for a randomised controlled trial.

artículo científico publicado en 2015

Cardiovascular effects of selective cyclooxygenase-2 inhibitors

artículo científico publicado en 2004

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

artículo científico publicado en 2006

Cardiovascular role of urotensin II: effect of chronic infusion in the rat.

artículo científico publicado en 2004

Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia

scientific journal article

Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.

artículo científico publicado en 2014

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

artículo científico publicado en 2009

Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone

artículo científico publicado en 2010

Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uremic Toxin, Indoxyl Sulfate ⬇️

artículo científico publicado el 19 de julio de 2012

Chronic heart failure--optimising care in general practice.

artículo científico publicado en 2005

Chronic heart failure.

artículo científico publicado en 2005

Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy.

artículo científico publicado en 2010

Circuit Resistance Training in Chronic Heart Failure Improves Skeletal Muscle Mitochondrial ATP Production Rate—A Randomized Controlled Trial

article

Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study

artículo científico publicado en 2013

Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial

artículo científico publicado en 2015

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

artículo científico publicado en 2005

Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial

artículo científico publicado en 2008

Clinical investigations of statins in heart failure: ventricular function and anti-remodeling

artículo científico publicado en 2008

Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).

artículo científico publicado en 2015

Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial

artículo científico publicado en 2013

Clinical service organisation for heart failure

artículo científico publicado en 2012

Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003

artículo científico publicado en 2007

Coenzyme Q10 in cardiovascular disease

artículo científico publicado en 2007

Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis

Comment on "Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS-III, by JGF Cleland and others".

artículo científico publicado en 2006

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

artículo científico publicado en 2002

Comparison of predictive performance of renal function estimation equations for all-cause and cardiovascular mortality in an elderly hypertensive population

artículo científico publicado en 2014

Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.

artículo científico publicado en 2004

Contemporary predictors of coronary artery disease in patients referred for angiography

artículo científico publicado en 2010

Contributors

Cost effectiveness of eplerenone in patients with chronic heart failure

artículo científico publicado en 2014

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms

artículo científico publicado en 2014

Could risk stratification aid the treatment of patients with acute decompensated heart failure?

artículo científico publicado en 2005

Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data

artículo científico publicado en 2013

Current modalities for invasive and non-invasive monitoring of volume status in heart failure: Table 1 ⬇️

artículo científico publicado el 9 de mayo de 2012

Current role of neprilysin inhibitors in hypertension and heart failure

artículo científico publicado en 2014

Current status of endothelin blockade for the treatment of cardiovascular and pulmonary vascular disease.

artículo científico publicado en 2003

Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant?

artículo científico publicado en 2003

Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study

artículo científico publicado en 2018

Decade in review--heart failure: 10 Years of progress in HF research--what have we learned?

artículo científico

Demographics and concomitant disorders in heart failure

artículo científico publicado en 2003

Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system

artículo científico publicado en 2011

Diabetes, left ventricular systolic dysfunction, and chronic heart failure

artículo científico publicado en 2008

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial

artículo científico publicado en 2010

Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measure

artículo científico publicado en 2017

Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure

artículo científico publicado en 2004

Digoxin Withdrawal Worsens Clinical Status in Stable Patients With Heart Failure Receiving Optimal Contemporaneous Therapy—A Randomized Controlled Trial

artículo científico publicado en 2015

Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants

artículo científico publicado en 2014

Direct Left Atrial Pressure Monitoring in Severe Heart Failure: Long-Term Sensor Performance ⬇️

artículo científico publicado el 14 de octubre de 2010

Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy

artículo científico publicado en 2003

Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device

artículo científico publicado en 2007

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (

article

Diuretics in the treatment of heart failure: mainstay of therapy or potential hazard?

artículo científico publicado en 2006

Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial

artículo científico publicado en 2010

Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis

artículo científico publicado en 2009

Do Cardiac Rehabilitation Programs Offer Cardiopulmonary Resuscitation Training in Australia and New Zealand?

artículo científico publicado en 2015

Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials

scientific article published on 01 April 2005

Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?

artículo científico publicado en 2010

Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction? A multicentre study

artículo científico publicado en 2006

Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure

artículo científico publicado en 2007

Drug discovery for heart failure: a new era or the end of the pipeline?

artículo científico publicado en 2007

Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence

artículo científico publicado en 2006

Early and delayed tranilast treatment reduces pathological fibrosis following myocardial infarction.

artículo científico publicado en 2012

Effect of Gender on Outcomes After Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex: A Subgroup Analysis of the EchoCRT Trial

artículo científico

Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension ⬇️

artículo científico publicado el 25 de abril de 2011

Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure

artículo científico publicado en 2017

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis

artículo científico publicado en 2016

Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension

artículo científico publicado en 2005

Effect of atorvastatin on cardiac remodelling and mortality in rats following hyperglycemia and myocardial infarction.

artículo científico publicado en 2009

Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial

artículo científico publicado en 2017

Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT.

artículo científico publicado en 2016

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

artículo científico publicado en 2002

Effect of endothelin blockade on basal and stimulated forearm blood flow in patients with essential hypertension

scientific article published on 01 March 2002

Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension

artículo científico publicado en 2005

Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).

artículo científico publicado en 2013

Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial

artículo científico publicado en 2012

Effect of nateglinide on the incidence of diabetes and cardiovascular events

artículo científico publicado en 2010

Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy

artículo científico publicado en 2010

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.

artículo científico publicado en 2004

Effect of valsartan on the incidence of diabetes and cardiovascular events

artículo científico publicado en 2010

Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial

artículo científico publicado en 2011

Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.

artículo científico publicado en 2005

Effects of Renal Denervation on Sympathetic Activation, Blood Pressure, and Glucose Metabolism in Patients with Resistant Hypertension ⬇️

artículo científico publicado el 2 de febrero de 2012

Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial

artículo científico publicado en 2017

Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction.

artículo científico publicado en 2008

Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial

artículo científico

Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis

artículo científico publicado en 2011

Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study

artículo científico publicado en 2003

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials

artículo científico publicado en 2007

Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients

artículo científico publicado en 2002

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis

artículo científico publicado en 2014

Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study

artículo científico publicado en 2012

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

artículo científico publicado en 2012

Eplerenone for the treatment of cardiovascular disorders

artículo científico

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms ⬇️

artículo científico publicado el 14 de noviembre de 2010

Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations

artículo científico

Eplerenone in the treatment of chronic heart failure.

artículo científico publicado en 2004

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

artículo científico publicado en 2005

Eplerenone. Pharmacia

artículo científico publicado el 1 de marzo de 2003

Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates

artículo científico publicado en 2009

Evaluation of the effects of urotensin II and soluble epoxide hydrolase inhibitor on skin microvessel tone in healthy controls and heart failure patients

artículo científico publicado en 2011

Expanding indications for pacing in chronic heart failure.

artículo científico publicado en 2009

FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy

artículo científico publicado en 2012

FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy

artículo científico publicado en 2012

Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.

artículo científico publicado en 2009

Factors influencing family physician adherence to hypertension treatment guideline recommendations on the initiation of pharmacotherapy: questionnaire survey

scientific article published on 01 January 2003

Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.

artículo científico publicado en 2008

Fibrosis as a therapeutic target post-myocardial infarction.

artículo científico publicado en 2005

Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial).

artículo científico publicado en 2016

Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006.

artículo científico publicado en 2006

Health-Related Quality of Life After Renal Denervation in Patients With Treatment-Resistant Hypertension ⬇️

artículo científico publicado el 15 de octubre de 2012

Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps

artículo científico publicado en 2016

Heart failure and nephropathy: catastrophic and interrelated complications of diabetes

artículo científico publicado en 2005

Heart failure care in low- and middle-income countries: a systematic review and meta-analysis

artículo científico publicado en 2014

Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy

artículo científico

Heart failure, ventricular dysfunction and risk factor prevalence in Australian Aboriginal peoples: the Heart of the Heart Study

artículo científico publicado en 2012

Heart failure: preventing disease and death worldwide

artículo científico publicado en 2014

History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure

artículo científico publicado en 2008

How does renal denervation lower blood pressure and when should this technique be considered for the treatment of hypertension?

artículo científico publicado en 2013

Images in cardiovascular medicine. Dynamic myocardial ischemia caused by circumflex artery stenosis detected by a new implantable left atrial pressure monitoring device

artículo científico publicado en 2006

Impact of Statin Therapy on Clinical Outcomes in Chronic Heart Failure Patients According to Beta-Blocker Use: Results of CIBIS II

scientific article published on 08 September 2006

Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial

artículo científico publicado en 2015

Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia

Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography

artículo científico publicado en 2012

Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial

artículo científico publicado en 2012

Impaired pulmonary diffusing capacity and hypoxia in heart failure correlates with central sleep apnea severity

artículo científico publicado en 2008

In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling

artículo científico publicado en 2005

Incidence of heart failure in 6083 elderly hypertensive patients: the Second Australian National Blood Pressure Study (ANBP2).

artículo científico publicado en 2015

Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: result

artículo científico

Increased circulating urotensin II in cirrhosis: potential implications in liver disease.

artículo científico publicado en 2007

Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease

artículo científico publicado en 2015

Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design

artículo científico publicado en 2013

Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study

artículo científico publicado en 2004

Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction

artículo científico publicado en 2005

International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension

artículo científico publicado en 2013

International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation

artículo científico publicado en 2012

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up.

artículo científico publicado en 2005

Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial

artículo científico publicado en 2012

Is target dose of beta-blocker more important than achieved heart rate or heart rate change in patients with systolic chronic heart failure?

artículo científico publicado en 2010

Letter by Connelly et al regarding article, "Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension"

artículo científico publicado en 2008

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials

artículo científico publicado en 2017

Long-term survival following the development of heart failure in an elderly hypertensive population

artículo científico

Losartan increases bradykinin levels in hypertensive humans

artículo científico publicado en 2005

Losing ALTITUDE? How should ASTRONAUT launch into ATMOSPHERE.

artículo científico publicado en 2013

Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Stud

artículo científico publicado en 2017

Medical therapy for chronic heart failure ⬇️

artículo científico publicado el 20 de agosto de 2011

Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients

artículo científico publicado en 2014

Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure

artículo científico publicado en 2005

Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting

artículo científico publicado en 2010

Microglia activation in the hypothalamic PVN following myocardial infarction.

artículo científico publicado en 2010

Mineralcorticoid antagonists in heart failure

artículo científico publicado en 2014

Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow.

artículo científico publicado en 2004

Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT).

artículo científico publicado en 2004

More Changing Times at Cardiovascular Therapeutics

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

artículo científico publicado en 2007

N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).

artículo científico publicado en 2013

NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).

artículo científico publicado en 2013

NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy

artículo científico publicado en 2004

Nebulized furosemide for the management of dyspnea: does the evidence support its use?

artículo científico publicado en 2008

Neprilysin inhibitors preserve renal function in heart failure

artículo científico publicado en 2014

New developments in the pharmacological treatment of chronic heart failure

artículo científico publicado en 2003

New medical therapies for heart failure

artículo científico

New therapeutic approaches to resistant hypertension

artículo científico publicado en 2010

New treatment for old disease: management of resistant hypertension by percutaneous renal sympathetic denervation

artículo científico

Noninvasive calibration of cardiac pressure transducers in patients with heart failure: an aid to implantable hemodynamic monitoring and therapeutic guidance

artículo científico publicado en 2006

Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial.

artículo científico publicado en 2008

Novel Drug Treatments for Hypertension

Novel procedure- and device-based strategies in the management of systemic hypertension

artículo científico publicado en 2011

Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders

artículo científico publicado en 2007

Novel therapies in acute and chronic heart failure ⬇️

artículo científico publicado el 23 de marzo de 2012

Nurse-Led Titration of β-Adrenoreceptor Blocking Agents in Chronic Heart Failure Patients in the Community

artículo científico publicado en 2010

Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents and angiotensin receptor blockers for patients with left ventricular systolic dysfunction

artículo científico publicado en 2012

Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction

artículo científico publicado en 2015

Nursing sans frontières: a three year case study of multi-state registration to support nursing practice using information technology.

artículo científico publicado en 2006

Optimising management of chronic heart failure

artículo científico publicado en 2009

Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific).

artículo científico publicado en 2011

Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the Which? trial

artículo científico publicado en 2013

Peptidomic profiles of post myocardial infarction rats affinity depleted plasma using matrix-assisted laser desorption/ionization time of flight (MALDI-ToF) mass spectrometry

artículo científico publicado en 2012

Pharmacologic management of the cardiorenal syndrome in heart failure

scientific article published on June 2009

Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials

artículo científico publicado en 2007

Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir

artículo científico publicado en 2008

Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure

artículo científico

Physiologic determinants of endothelin concentrations in human saliva.

artículo científico publicado en 2003

Polypharmacy in heart failure - Is reducing medication safe?

artículo científico publicado en 2015

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice

artículo científico publicado en 2005

Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS.

artículo científico

Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study

artículo científico publicado en 2013

Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort

artículo científico publicado en 2002

Prevalence of heart failure in Australia: a systematic review

artículo científico publicado en 2016

Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials

artículo científico

Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction

artículo científico publicado en 2016

Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors

artículo científico publicado en 2005

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

artículo científico publicado en 2004

Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trial

artículo científico publicado en 2017

Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol

artículo científico publicado en 2013

Protein kinases as cardiovascular therapeutic targets.

artículo científico publicado en 2014

Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome

artículo científico publicado en 2016

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Blood Pressure-Lowering Effect of Renal Denervation

artículo científico publicado en 2016

RAAS inhibitors and cardiovascular protection in large scale trials

artículo científico publicado en 2013

Radial artery pulse wave analysis for non-invasive assessment of coronary artery disease ⬇️

artículo científico publicado el 4 de abril de 2012

Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia

artículo científico publicado en 2008

Rate of change in renal function and mortality in elderly treated hypertensive patients

artículo científico publicado en 2015

Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease

artículo científico publicado en 2012

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney diseas

artículo científico publicado en 2015

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).

artículo científico publicado en 2010

Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE)

artículo científico publicado en 2003

Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure

artículo científico publicado en 2016

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

artículo científico publicado en 2009

Recent advances in the management of chronic heart failure

scientific article published on 01 January 2003

Reduced exercise tolerance in CHF may be related to factors other than impaired skeletal muscle oxidative capacity.

artículo científico publicado en 2004

Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy

artículo científico

Reliability of isokinetic strength and aerobic power testing for patients with chronic heart failure

scientific article published on 01 July 2002

Renal Denervation and Hypertension ⬇️

artículo científico publicado el 10 de marzo de 2011

Renal Denervation in Human Hypertension: Mechanisms, Current Findings, and Future Prospects ⬇️

artículo científico publicado el 1 de junio de 2012

Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension

artículo científico publicado en 2015

Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept

scientific article published on 12 October 2009

Renal denervation in moderate to severe CKD.

artículo científico publicado en 2012

Renal denervation: a potential new treatment modality for polycystic ovary syndrome?

scientific article published on 01 May 2011

Renal denervation: current implications and future perspectives

artículo científico publicado en 2014

Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension

artículo científico publicado en 2012

Renal nerve ablation reduces augmentation index in patients with resistant hypertension

artículo científico publicado en 2013

Renal sympathetic denervation for the treatment of refractory hypertension

artículo científico

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

artículo científico publicado en 2010

Renal sympathetic nerve ablation for treatment-resistant hypertension

artículo científico

Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension

artículo científico publicado en 2010

Renal sympathetic-nerve ablation for uncontrolled hypertension

artículo científico publicado en 2009

Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure

artículo científico publicado en 2013

Response to quality of life after renal denervation

artículo científico publicado en 2013

Role of renin in heart failure and therapeutic potential of direct renin inhibition

artículo científico publicado en 2008

Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease

artículo científico publicado en 2002

Rural and urban differentials in primary care management of chronic heart failure: new data from the CASE study.

artículo científico publicado en 2007

SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF): early detection of chronic heart failure in the workplace

artículo científico publicado en 2016

Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function

article

Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial

artículo científico publicado en 2008

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

artículo científico publicado en 2013

Selective cyclo-oxygenase-2 inhibitors and myocardial infarction: how strong is the link?

artículo científico publicado en 2002

Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials

scientific article published on 06 November 2011

Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study

artículo científico

Short-term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in the second Australian National Blood Pressure Study (ANBP2)

artículo científico publicado en 2003

Should patients with chronic heart failure be treated with "statins"?

artículo científico publicado en 2003

Sleep apnea in heart failure increases heart rate variability and sympathetic dominance.

artículo científico publicado en 2007

Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction

artículo científico publicado en 2012

Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).

artículo científico publicado en 2008

Statins and chronic heart failure: do we need a large-scale outcome trial?

artículo científico publicado en 2002

Statins and clinical outcomes in heart failure

artículo científico publicado en 2007

Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT

scientific article published on 17 October 2006

Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension ⬇️

artículo científico publicado el 19 de noviembre de 2012

Sustained activation of microglia in the hypothalamic PVN following myocardial infarction.

artículo científico publicado en 2012

Sympatho-renal axis in chronic disease ⬇️

artículo científico publicado el 19 de junio de 2011

Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure

artículo científico publicado en 2003

Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients

artículo científico publicado en 2014

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

artículo científico publicado en 2004

Targeting Fibrosis for the Treatment of Heart Failure: A Role for Transforming Growth Factor‐β ⬇️

artículo científico publicado el 23 de septiembre de 2010

Telemonitoring of fluid status in heart failure: CHAMPION ⬇️

artículo científico publicado el 19 de febrero de 2011

Telephone support to rural and remote patients with heart failure: the Chronic Heart Failure Assessment by Telephone (CHAT) study.

artículo científico publicado en 2013

Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).

artículo científico publicado en 2005

The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics.

artículo científico publicado en 2015

The Heartpod implantable heart failure therapy system

artículo científico publicado en 2005

The Ongoing Evolution of Optimal Clinical Endpoints for Heart Failure Trials

artículo científico publicado en 2015

The Role of Renal Denervation in the Treatment of Heart Failure ⬇️

artículo científico publicado el 1 de junio de 2012

The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design

artículo científico publicado en 2007

The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005).

artículo científico publicado en 2005

The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure

artículo científico publicado en 2012

The black dog and the weak heart: comorbid depression in the patient with heart failure

artículo científico publicado en 2008

The cardiac (pro)renin receptor is primarily expressed in myocyte transverse tubules and is increased in experimental diabetic cardiomyopathy ⬇️

artículo científico publicado el 1 de junio de 2011

The cardiovascular safety of celecoxib

artículo científico publicado en 2005

The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial

artículo científico publicado en 2015

The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction

artículo científico publicado en 2009

The future of pharmacological therapy for heart failure

artículo científico publicado en 2010

The impact of baseline HR and BP on the tolerability of carvedilol in the elderly: the COLA (Carvedilol Open Label Assessment) II Study

artículo científico publicado en 2006

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial

artículo científico publicado en 2013

The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study

scientific article published on 01 March 2015

The role of aldosterone receptor blockade in the management of cardiovascular disease

artículo científico publicado en 2002

The thrill of success: central arterial-venous anastomosis for hypertension

artículo científico publicado en 2014

The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice

artículo científico publicado en 2016

The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction

artículo científico publicado en 2013

The use of beta3-adrenergic receptor agonists in the treatment of heart failure

artículo científico publicado en 2009

The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial

artículo científico publicado en 2015

Therapeutic potential of blockade of the urotensin II system in systemic hypertension

artículo científico publicado en 2007

To the heart of the matter: coxibs, smoking, and cardiovascular risk

artículo científico publicado en 2005

Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study

artículo científico publicado en 2005

Tolerability of beta-blockers in heart failure: reassurance needed, reassurance provided

artículo científico publicado en 2003

Tolerability of carvedilol in heart failure: clinical trials experience

artículo científico publicado en 2004

Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial

artículo científico publicado en 2018

Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta

artículo científico publicado en 2005

Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy

scientific article published on 24 August 2007

Tumor necrosis factor-alpha blockade as a therapeutic strategy in heart failure (RENEWAL and ATTACH): unsuccessful, to be specific

artículo científico publicado en 2002

Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm

artículo científico publicado en 2013

Urotensin II Levels Are an Important Marker for the Severity of Portal Hypertension in Children ⬇️

artículo científico publicado el 1 de julio de 2011

Urotensin II in chronic liver disease: in vivo effect on vascular tone

artículo científico publicado en 2008

Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats

artículo científico publicado en 2009

Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension

artículo científico publicado en 2007

Urotensin II: a vascular mediator in health and disease

artículo científico publicado en 2005

Urotensin-II as a novel therapeutic target in the clinical management of cardiorenal disease.

artículo científico publicado en 2004

Using adult stem cells to treat heart failure--fact or fiction?

artículo científico publicado en 2008

Utility of B-type natriuretic peptide as a screen for left ventricular dysfunction in patients with diabetes: response to Epshteyn et al

artículo científico publicado en 2004

What is the methodological and reporting quality of health related quality of life in chronic heart failure clinical trials?

artículo científico publicado en 2012

Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study

artículo científico publicado en 2010

Why do phase III trials of promising heart failure drugs often fail? the contribution of “regression to the truth” ⬇️

artículo científico publicado el 1 de octubre de 2003

Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study

article

Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction

artículo científico publicado en 2013

p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat

artículo científico publicado en 2004

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda